These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28756311)

  • 1. Neurogenesis impairment: An early developmental defect in Down syndrome.
    Stagni F; Giacomini A; Emili M; Guidi S; Bartesaghi R
    Free Radic Biol Med; 2018 Jan; 114():15-32. PubMed ID: 28756311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for Down syndrome.
    Trazzi S; Fuchs C; Valli E; Perini G; Bartesaghi R; Ciani E
    J Biol Chem; 2013 Jul; 288(29):20817-20829. PubMed ID: 23740250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Trazzi S; Fuchs C; De Franceschi M; Mitrugno VM; Bartesaghi R; Ciani E
    Neurobiol Dis; 2014 Jul; 67():24-36. PubMed ID: 24636797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
    Kurabayashi N; Sanada K
    Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome.
    Stagni F; Salvalai ME; Giacomini A; Emili M; Uguagliati B; Xia E; Grilli M; Bartesaghi R; Guidi S
    Neurobiol Dis; 2019 Sep; 129():44-55. PubMed ID: 31085229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome.
    Guidi S; Ciani E; Bonasoni P; Santini D; Bartesaghi R
    Brain Pathol; 2011 Jul; 21(4):361-73. PubMed ID: 21040072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.
    Contestabile A; Benfenati F; Gasparini L
    Prog Neurobiol; 2010 May; 91(1):1-22. PubMed ID: 20097253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
    Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
    Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Annerén G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
    Mol Neurobiol; 2019 Oct; 56(10):7113-7127. PubMed ID: 30989628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.
    Valenti D; de Bari L; de Rasmo D; Signorile A; Henrion-Caude A; Contestabile A; Vacca RA
    Biochim Biophys Acta; 2016 Jun; 1862(6):1093-104. PubMed ID: 26964795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
    Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
    Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro.
    Araujo BHS; Kaid C; De Souza JS; Gomes da Silva S; Goulart E; Caires LCJ; Musso CM; Torres LB; Ferrasa A; Herai R; Zatz M; Okamoto OK; Cavalheiro EA
    Mol Neurobiol; 2018 Jul; 55(7):5962-5975. PubMed ID: 29128905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome.
    Emili M; Stagni F; Bonasoni MP; Guidi S; Bartesaghi R
    Dev Neurobiol; 2024 Oct; 84(4):264-273. PubMed ID: 39344402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.
    Lu J; Lian G; Zhou H; Esposito G; Steardo L; Delli-Bovi LC; Hecht JL; Lu QR; Sheen V
    Hum Mol Genet; 2012 May; 21(10):2330-40. PubMed ID: 22343408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
    Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
    Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.